Anzeige
Mehr »
Montag, 09.02.2026 - Börsentäglich über 12.000 News
Goldman sieht 15.000 USD bei Kupfer - dieser Explorer ist noch völlig unbekannt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
231 Leser
Artikel bewerten:
(0)

Capio Appoints Attila Vegh as New CEO

GÖTHENBURG, Sweden, June 21, 2018 /PRNewswire/ -- The Board of Directors of Capio AB has today appointed Attila Vegh as the new President and CEO for Capio AB. He is currently CEO of Penta Hospitals International, the leading hospital chain in Central and Eastern Europe. Attila Vegh will replace Thomas Berglund within a 6 month period. Thomas will stay in position until the new CEO takes office.

"I am pleased to announce the appointment of Attila Vegh as the new CEO for Capio. He will bring a wide range of experience combined with a dedication to manage change and transformation in clinical environments, both in the private and the public sector", says Michael Wolf, Chairman of the Board of Capio AB. "I also want to take the opportunity to express my and the Boards gratitude to Thomas Berglund who has served Capio for the last ten years. Under his leadership Capio has established itself as market leader through the strategies of Modern Medicine, Rapid Recovery and Modern Management ", continues Michael Wolf.

Attila Vegh is a trained doctor with a proven track record as a CEO. He's aged 42 and is currently CEO of Penta Hospitals International, a multi-national healthcare group with over 70 hospitals and clinics in three countries, employing over 14,000 staff. Previous positions include CEO of University Hospitals of South Manchester and CEO at Cambridgeshire and Peterborough Foundation Trust in the United Kingdom. Prior to his CEO roles, Attila Vegh spent five years at McKinsey & Company, leading the transformation programs of large hospital groups across Europe, US and Asia. In addition to his medical training, he also holds a Ph.D in Molecular Cancer Research from the University of Paris and an MSc in Health Management from Imperial College London.

"I am looking forward to joining Capio, which has a strong international reputation. Healthcare markets are transforming and with Capios strong medical knowledge and operational capabilities, I see exciting potential for its future development. Together with the management team, I look forward to further advancing the company by accelerating the execution of the Capio strategy, with a strong focus on specialization and digitalization", says Attila Vegh.

"With the appointment of Attila Vegh we secure a strong and proven manager for Capio and we will now accelerate our strategy to drive medical quality, growth and shareholder value. To ensure this development, the Board and management continuously review operational and structural measures on the back of our increased focus on specialization and digitalization" ends Michael Wolf.

For information, please contact:
Michael Wolf
Chairman of the Board, Capio AB
Telephone: +46-761-11-34-14

This is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 (CET) on June 21, 2018.

Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2017, Capio's 13,314 employees (average full-time equivalents) provided healthcare services during 5.1 million patient visits across the Group's facilities, generating net sales of MSEK 15,327. Capio operates across three geographic segments: Nordic (57% of Group net sales 2017), France (35% of Group net sales 2017) and Germany (8% of Group net sales 2017). For more information about Capio, please see www.capio.com.

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/capio-ab/r/capio-appoints-attila-vegh-as-new-ceo,c2554619

The following files are available for download:

http://mb.cision.com/Main/277/2554619/864348.pdf

Press release (PDF)

http://news.cision.com/capio-ab/i/attila-vegh,c2438717

Attila Vegh

© 2018 PR Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.